The Affordable Inhalers and Nebulizers Act of 2025 is designed to enhance access to inhalers and nebulizers for individuals suffering from breathing disorders such as asthma and chronic obstructive pulmonary disease (COPD). The legislation aims to alleviate the financial strain on patients by capping their out-of-pocket expenses for these essential medications. Key provisions of the Act mandate that health insurance plans cover all specified inhaler products without imposing any deductibles.